A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
NCT03725358 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2020-10-08
Summary
The study investigators propose to test various supply-side approaches to increase the numbers of both SARCs (short-acting reversible contraceptives, i.e. the pill and injectable) and especially LARCs (long-acting reversible contraceptives, i.e. the IUD and implant) administered by health facilities to reproductive-age females in Cameroon, particularly adolescents who may be unmarried and/or nulliparous. The study investigators will do this via interventions at primary health facilities, which include training of providers on family planning; the introduction of a tablet-based decision support tool for counseling women on family planning; and increased subsidies for LARCs within the performance-based financing (PBF) system. This approach is expected to benefit the population directly by decreasing maternal mortality and undesired pregnancies and indirectly by reducing side effects that arise due to current one-size-fits-all FP (family planning) counseling; improving the health of children due to improved birth spacing; and increasing human capital accumulation among children and young (often school-age) potential mothers.
Conditions
- Contraception Behavior
- Contraceptive Usage
- Contraceptive Method Switching
- Contraception
Interventions
- BEHAVIORAL
-
Training
Health facilities assigned to this group will receive a two-week training intervention on modern contraceptive methods and counseling techniques - aimed at nurses conducting family planning services. This new curriculum was developed by a large group of experts convened by the Ministry of Health in February 2018. The cascade training that is developed by the national government (cascading down to regions, districts, and finally health facilities) is a 15-day training module that targets family planning nurses, covering theory, practical knowledge (practicing administrations and removals), and counseling of clients.
- BEHAVIORAL
-
App
Health facilities assigned to this group will receive the same programming as the facilities in S1, but they will also be provided with tablets equipped with the "job aid," which subsumes the basic data collection software used by the remaining facilities. They will also receive additional training on the use of the tablet-based "job aid." The "app" is a tablet-based decision-support tool, which is designed for use by the family planning nurse conducting counseling sessions and records the answers to a series of questions that elicit the client's life goals, fertility plans, needs, and preferences regarding contraceptive methods, as well as her medical eligibility (birth history, pregnancy check, breastfeeding status, blood pressure, medications, etc.).
- BEHAVIORAL
-
Control
The comparison group includes facilities that continue business as usual (no FP training or tablet-based job aid). Each facility in this group will receive a tablet equipped with basic data collection software and a one-day training to use the tablets.
Sponsors & Collaborators
- collaborator OTHER
-
George Washington University
collaborator OTHER -
University of Exeter
collaborator OTHER -
University of California, San Diego
collaborator OTHER -
Yaounde Gynecology, Obstetrics and Pediatrics Hospital
collaborator UNKNOWN -
World Bank
lead OTHER
Principal Investigators
-
Berk Ozler, PhD · World Bank
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 10 Years
- Max Age
- 49 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-30
- Primary Completion
- 2022-09-30
- Completion
- 2023-01-31
More Related Trials
-
Patient Compliance With Long-Acting Reversible Contraception Administration
NCT03305081 ·Status: TERMINATED ·Phase: NA
-
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
NCT00995150 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Birth Control Use After Childbirth
NCT01443533 ·Status: COMPLETED ·Phase: NA
-
Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk
NCT02357368 ·Status: COMPLETED ·Phase: PHASE4
-
Perceptions of LARC Among AYA With Chronic Illness
NCT05000489 ·Status: COMPLETED
-
Impact of Video Intervention on Postabortal Uptake of Long Acting Reversible Contraception (LARC)
NCT01945385 ·Status: COMPLETED ·Phase: NA
-
LARC Forward Contraceptive Counseling at MHCC
NCT02735551 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy
NCT00996580 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
NCT03642210 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Impact of an Oral and Practical Presentation of Intrauterine Devices by a Health Professional on Women's Opinion as a Possible Contraceptive Method
NCT05317715 ·Status: UNKNOWN ·Phase: NA
-
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
NCT05444582 ·Status: RECRUITING ·Phase: PHASE4
-
Using Focus Group to Explore Cultural Acceptability of Contraception
NCT02945670 ·Status: COMPLETED
-
Long-Acting Reversible Contraception
NCT01299116 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive
NCT03506399 ·Status: WITHDRAWN ·Phase: PHASE1
-
Assessment of Cultural Acceptability of Long Acting Contraception in a Diverse, Urban Population
NCT03486743 ·Status: COMPLETED ·Phase: NA
-
Influence of Peer Mentoring on Adolescent Contraceptive Decision Making
NCT02157285 ·Status: COMPLETED ·Phase: NA
-
Use of an Educational Multimedia Tool Versus Routine Care for the Uptake of Postpartum LARC in High-Risk Pregnancies
NCT04291040 ·Status: UNKNOWN ·Phase: NA
-
Immediate Versus Delayed Initiation of Intrauterine System
NCT03708809 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
NCT04143659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
NCT00362479 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of ESSURE Devices Withdrawal on the Symptomatology of Patients
NCT03623126 ·Status: COMPLETED
-
The Evidence for Contraceptive Options and HIV Outcomes Trial
NCT02550067 ·Status: COMPLETED ·Phase: NA
-
The Share Health Study: Teen Social Connections and Health (Phase 2)
NCT03842540 ·Status: COMPLETED ·Phase: NA
-
Immediate Versus Delayed Insertion of Implanon in Postpartum Adolescents
NCT03585504 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
NCT01178125 ·Status: COMPLETED ·Phase: PHASE3